Search Within

Mark Andrew Dickson

Formats
  1. Journal Article (84)
  2. Meeting Abstract (83)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (169)
  2. Sarcoma Service (169)
  3. Solid Tumor Oncology Division (169)
  4. GSK Faculty (92)
  5. Hematologic Malignancies, Division of (86)
  6. Tow Center for Developmental Oncology (TCDO) (78)

More Groups

People
  1. William Tap (90)
  2. Sandra D'Angelo (83)
  3. Mary Keohan (75)
  4. Mrinal Gounder (69)
  5. Li-Xuan Qin (56)
  6. Ping Chi (54)

More People

Years
  1. 2025 (3)
  2. 2024 (13)
  3. 2023 (13)
  4. 2022 (19)
  5. 2021 (6)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Clinical Cancer Research (17)
  3. Annals of Oncology (8)
  4. European Journal of Cancer (5)
  5. Nature Communications (5)
  6. The Oncologist (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (75)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (14)
  4. Oxford University Press (13)
  5. Nature Publishing Group (10)
  6. Springer (6)

More Publishers

Results (169)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications
    Meeting Abstract

    D'Angelo, S. P.; Antonescu, C. R.; Keohan, M. L.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Moraco, N. H.; Singer, S.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy
    Meeting Abstract

    Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Infliximab (IFX) for ipilimumab (IPI)-induced colitis in melanoma patients (pts)
    Meeting Abstract

    Harding, J. J.; Callahan, M.; Postow, M.; Rocco, K.; D'Angelo, S.; Dickson, M.; Carvajal, R.; Schwartz, G. K.; Wolchok, J.; Chapman, P.
    Pigment Cell & Melanoma Research (2012)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: Preclinical investigations and results of a phase I dose-escalation clinical trial
    Journal Article

    Luke, J. J.; D'adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Maki, R. G.; de Stanchina, E.; Musi, E.; Singer, S.; Schwartz, G. K.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Open-label, sequential, ascending, multi-dose, phase I study of KW-2450 as monotherapy in subjects with previously treated advanced solid tumors
    Meeting Abstract

    Dickson, M. A.; LoRusso, P.; Sausville, E. A.; Rao, N.; Kobayashi, E.; Kurman, M. R.; Akinaga, S.; Schwartz, G. K.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors
    Journal Article

    Dickson, M. A.; Rathkopf, D. E.; Carvajal, R. D.; Grant, S.; Roberts, J. D.; Reid, J. M.; Ames, M. M.; McGovern, R. M.; Lefkowitz, R. A.; Gonen, M.; more...
    Investigational New Drugs (2011)

    Fulltext@MSK | Save
  • Phase i study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
    Journal Article

    Schwartz, G. K.; LoRusso, P. M.; Dickson, M. A.; Randolph, S. S.; Shaik, M. N.; Wilner, K. D.; Courtney, R.; O'Dwyer, P. J.
    British Journal of Cancer (2011)

    Fulltext@MSK | Save
  • A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors
    Journal Article

    Dickson, M. A.; Carvajal, R. D.; Merrill, A. H. Jr; Gonen, M.; Cane, L. M.; Schwartz, G. K.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save